Equity
PROSANA has made a profit without a break since 2023.
PROSANA has made a profit without a break since 2023.
The abbreviated format states no turnover.
The last five annual accounts were filed 26 to 113 days before the end of the period.
Heads a group.
Higher net result than 95% of companies in retail trade. Sector median €27,425 · 12,844 companies.
The dashed line is the sector median: 0.4% across 3,697 companies (NACE 47, small).
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 54% of them on solvency, 64% on liquidity, 18% on profitability and 75% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Liquidity is insufficient, with a current ratio of 0.6 (0.32 in 2024), below 1. Short-term debt is 10.5% and cash 0.6% of total assets. 65.8% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 6 accounts on average 64 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Shares in 3 companies, including Aa.Pharma Oosthoven and Aa.Pharma Oud-Turnhout
Board & ownership| Company | ||||
|---|---|---|---|---|
| PROSANA Oud-Turnhout | - | - | 34.2% | - |
| Cornette An Steenokkerzeel | - | - | 70.2% | - |
| CHRISTELLE DEROUX Braine-l'Alleud | - | - | 48.0% | - |
| PHI-BIS Malle | €16.2m | 4.7% | 41.8% | 41 |
| XPHARMA Puurs-Sint-Amands | - | - | 29.0% | - |
| FARMAZORG Oudenburg | €19.5m | 1.1% | 35.6% | 76.5 |
| AK Herbo Pharma Charleroi | - | - | 18.0% | 0 |
These companies have the same main activity as PROSANA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €2.6m and €6.5m, founded between 2010 and 2021.
PROSANA files the abbreviated format. That format states no turnover. The gross margin rose from €30,300 in 2020 to €73,265 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.